Tick-borne encephalitis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 12: Line 12:
*This treatment may be likened to interferon treatment for [[Hepatitis C]].
*This treatment may be likened to interferon treatment for [[Hepatitis C]].
*Antibiotic treatment may be necessary for potential tick-borne co-infections, such as [[phytotherapy]].<ref>Streptomycin--an activator of persisting tick-borne encephalitis virus.{{cite journal | author = Malenko G, Pogodina V, Karmysheva V | title = [Streptomycin--an activator of persisting tick-borne encephalitis virus] | journal = Vopr Virusol | volume = 29 | issue = 2 | pages = 217-23 | year = 1984 | month=Mar-Apr | id = PMID 6730440}}</ref><ref>Experimental phytotherapy of tick-borne encephalitis.{{cite journal | author = Fokina G, Frolova T, Roĭkhel' V, Pogodina V | title = [Experimental phytotherapy of tick-borne encephalitis] | journal = Vopr Virusol | volume = 36 | issue = 1 | pages = 18-21 | year = 1991 | month=Jan-Feb | id = PMID 1858353}}</ref><ref>Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis.{{cite journal | author = Ozherelkov S, Timofeev A, Novikova G, Deeva A, Narovlianskiĭ A, Sanin A, Pronin A | title = [Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis] | journal = Vopr Virusol | volume = 45 | issue = 1 | pages = 33-7 | year = 2000 | month=Jan-Feb | id = PMID 10695042}} </ref>
*Antibiotic treatment may be necessary for potential tick-borne co-infections, such as [[phytotherapy]].<ref>Streptomycin--an activator of persisting tick-borne encephalitis virus.{{cite journal | author = Malenko G, Pogodina V, Karmysheva V | title = [Streptomycin--an activator of persisting tick-borne encephalitis virus] | journal = Vopr Virusol | volume = 29 | issue = 2 | pages = 217-23 | year = 1984 | month=Mar-Apr | id = PMID 6730440}}</ref><ref>Experimental phytotherapy of tick-borne encephalitis.{{cite journal | author = Fokina G, Frolova T, Roĭkhel' V, Pogodina V | title = [Experimental phytotherapy of tick-borne encephalitis] | journal = Vopr Virusol | volume = 36 | issue = 1 | pages = 18-21 | year = 1991 | month=Jan-Feb | id = PMID 1858353}}</ref><ref>Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis.{{cite journal | author = Ozherelkov S, Timofeev A, Novikova G, Deeva A, Narovlianskiĭ A, Sanin A, Pronin A | title = [Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis] | journal = Vopr Virusol | volume = 45 | issue = 1 | pages = 33-7 | year = 2000 | month=Jan-Feb | id = PMID 10695042}} </ref>
===Antibiotics===
*Although the TBE virus cannot be eradicated from the body, it can be inactivated. It can also be activated.<ref> The search for antibiotics not exerting activating action in the persistence of the tick-borne encephalitis virus. {{cite journal | author = Malenko G, Pogodina V | title = [The search for antibiotics not exerting activating action in the persistence of the tick-borne encephalitis virus] | journal = Vopr Virusol | volume = 34 | issue = 2 | pages = 197-200 | year = . 1989 | month=Mar-Apr | id = PMID 2788330}}</ref>
*Certain antibiotics activate the TBE virus while others have no effect. 
*TBE virus may be a coinfection with a Borrelia Burgdorferi infection, [[Lyme disease]], which needs treatment with antibiotics.
*The Russians studied this matter for years and their findings were as follows: gentamicin exerts no activating effect while streptomycin and ten other antibiotics activate the virus. <ref>Effect of gentamycin on persistence of tick-borne encephalitis.{{cite journal | author = Pogodina V, Malenko G, Karmysheva V, Frolova M | title = [Effect of gentamycin on persistence of tick-borne encephalitis] | journal = Vopr Virusol | volume = 44 | issue = 1 | pages = 35-9 | year = 1999 | month=Jan-Feb | id = PMID 10190241}}</ref>


==References==
==References==

Revision as of 15:50, 9 March 2016

Tick-borne encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tick-borne encephalitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

MRI

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Future or Investigational New Therapies

Prevention

Case Studies

Case #1

Tick-borne encephalitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tick-borne encephalitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tick-borne encephalitis medical therapy

CDC on Tick-borne encephalitis medical therapy

Tick-borne encephalitis medical therapy in the news

Blogs on Tick-borne encephalitis medical therapy

Directions to Hospitals Treating Tick-borne encephalitis

Risk calculators and risk factors for Tick-borne encephalitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ilan Dock, B.S.


Overview

Treatments for tick-borne encephalitis may be categorized according to a mainstay, phosphrenyl treatment, an antibiotic therapy, and homeopathic, herbal treatments. Phosphrenyl treatment is similar to interferon treatment for Hepatitis C, utilized as both a therapeutic and prophylactic agent. Antibiotic therapies are useful as many disease vectors responsible for transmission of tick-borne encephalitis also carry many other tick-borne diseases. An antibiotic therapy may be helpful in anticipating any potential tick-borne co-infections. Antibiotics have also been useful in deactivating certain characteristics of the virus. However certain antibiotic therapies have proven to activate the virus. Thus for this reason, certain antibiotics, such as streptomycin, should not be prescribed during the course of infection. Homeopathic therapies, such as ledum, motherwort, and blackcurrant have inactivating effects on tick-borne encephalitis virus.

Medical Therapy

  • The mainstay medical therapy for tick-borne encephalitis is [Phosphrenyl]] treatment.
  • Phosphrenyl treatment including both a therapeutic and prophylactic agent for TBEinterferon treatment.
  • This treatment may be likened to interferon treatment for Hepatitis C.
  • Antibiotic treatment may be necessary for potential tick-borne co-infections, such as phytotherapy.[1][2][3]

References

  1. Streptomycin--an activator of persisting tick-borne encephalitis virus.Malenko G, Pogodina V, Karmysheva V (1984). "[Streptomycin--an activator of persisting tick-borne encephalitis virus]". Vopr Virusol. 29 (2): 217–23. PMID 6730440. Unknown parameter |month= ignored (help)
  2. Experimental phytotherapy of tick-borne encephalitis.Fokina G, Frolova T, Roĭkhel' V, Pogodina V (1991). "[Experimental phytotherapy of tick-borne encephalitis]". Vopr Virusol. 36 (1): 18–21. PMID 1858353. Unknown parameter |month= ignored (help)
  3. Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis.Ozherelkov S, Timofeev A, Novikova G, Deeva A, Narovlianskiĭ A, Sanin A, Pronin A (2000). "[Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis]". Vopr Virusol. 45 (1): 33–7. PMID 10695042. Unknown parameter |month= ignored (help)